124 related articles for article (PubMed ID: 34519204)
1. Novel [
Li X; Shi S; Zhou H; Zhao Z; Lu J
Mol Pharm; 2021 Oct; 18(10):3811-3819. PubMed ID: 34519204
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
Vaidyanathan G; McDougald D; Koumarianou E; Choi J; Hens M; Zalutsky MR
Nucl Med Biol; 2015 Aug; 42(8):673-84. PubMed ID: 25956997
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of norepinephrine transporter-expressing tumors using 76Br-meta-bromobenzylguanidine.
Watanabe S; Hanaoka H; Liang JX; Iida Y; Endo K; Ishioka NS
J Nucl Med; 2010 Sep; 51(9):1472-9. PubMed ID: 20720048
[TBL] [Abstract][Full Text] [Related]
4. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
5. Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
Chen X; Fritz A; Werner RA; Nose N; Yagi Y; Kimura H; Rowe SP; Koshino K; Decker M; Higuchi T
Mol Imaging Biol; 2020 Jun; 22(3):602-611. PubMed ID: 31332629
[TBL] [Abstract][Full Text] [Related]
6. Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
Werner RA; Rischpler C; Onthank D; Lapa C; Robinson S; Samnick S; Javadi M; Schwaiger M; Nekolla SG; Higuchi T
J Nucl Med; 2015 Sep; 56(9):1429-33. PubMed ID: 26182969
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.
Yu M; Bozek J; Lamoy M; Guaraldi M; Silva P; Kagan M; Yalamanchili P; Onthank D; Mistry M; Lazewatsky J; Broekema M; Radeke H; Purohit A; Cdebaca M; Azure M; Cesati R; Casebier D; Robinson SP
Circ Cardiovasc Imaging; 2011 Jul; 4(4):435-43. PubMed ID: 21555377
[TBL] [Abstract][Full Text] [Related]
8.
López-Picón FR; Kirjavainen AK; Forsback S; Takkinen JS; Peters D; Haaparanta-Solin M; Solin O
Theranostics; 2019; 9(1):11-19. PubMed ID: 30662550
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
Zhang H; Huang R; Pillarsetty N; Thorek DL; Vaidyanathan G; Serganova I; Blasberg RG; Lewis JS
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):322-32. PubMed ID: 24173571
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
11. Molecular Imaging-Derived Biomarker of Cardiac Nerve Integrity - Introducing High NET Affinity PET Probe
Chen X; Werner RA; Koshino K; Nose N; Mühlig S; Rowe SP; Pomper MG; Lapa C; Decker M; Higuchi T
Theranostics; 2022; 12(9):4446-4458. PubMed ID: 35673571
[No Abstract] [Full Text] [Related]
12. Cardiac retention of PET neuronal imaging agent LMI1195 in different species: impact of norepinephrine uptake-1 and -2 transporters.
Yu M; Bozek J; Kagan M; Guaraldi M; Silva P; Azure M; Onthank D; Robinson SP
Nucl Med Biol; 2013 Jul; 40(5):682-8. PubMed ID: 23601914
[TBL] [Abstract][Full Text] [Related]
13.
Kirjavainen AK; Forsback S; López-Picón FR; Marjamäki P; Takkinen J; Haaparanta-Solin M; Peters D; Solin O
Nucl Med Biol; 2018 Jan; 56():39-46. PubMed ID: 29172120
[TBL] [Abstract][Full Text] [Related]
14. Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[
Lokitz SJ; Garg S; Nazih R; Garg PK
Mol Imaging Biol; 2019 Aug; 21(4):686-695. PubMed ID: 30250991
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Evaluation of
Yang L; Yin L; Hu M; Zhao W; Wang C; Chen Y; Li Z; Wang L
Mol Imaging Biol; 2023 Dec; 25(6):1125-1134. PubMed ID: 37580463
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Sympathetic Positron Emission Tomography Imaging with
Ismailani US; Buchler A; Farber G; Pekošak A; Farber E; MacMullin N; Suuronen EJ; Vasdev N; Beanlands RSB; de Kemp RA; Rotstein BH
ACS Chem Neurosci; 2021 Nov; 12(22):4350-4360. PubMed ID: 34714061
[TBL] [Abstract][Full Text] [Related]
18. 4-[18F]Fluoro-m-hydroxyphenethylguanidine: a radiopharmaceutical for quantifying regional cardiac sympathetic nerve density with positron emission tomography.
Jang KS; Jung YW; Gu G; Koeppe RA; Sherman PS; Quesada CA; Raffel DM
J Med Chem; 2013 Sep; 56(18):7312-23. PubMed ID: 23965035
[TBL] [Abstract][Full Text] [Related]
19. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[
Woo SK; Moon BS; Kim BS; Kim MH; Lee YJ; Jung JH; Lee KC; Seo Y; Kim W; Lim SM; Lee BC; Kim SE
Nucl Med Biol; 2018 Jun; 61():63-70. PubMed ID: 29783202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
